News Releases

April 2, 2018
Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with Cirrhosis
March 21, 2018
Synlogic to Present at the 17th Annual Needham Healthcare Conference
March 20, 2018
Synlogic Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
March 19, 2018
Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting
March 12, 2018
Synlogic Presents Clinical and Preclinical Data from Synthetic Biotic™ Medicine Programs for Treatment of Inborn Errors of Metabolism at Annual Meeting of The Society for Inherited Metabolic Disorders
March 5, 2018
Synlogic to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference
February 13, 2018
Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic™ Medicine
February 8, 2018
Synlogic to Present at the Leerink Partners 7th Annual Global Healthcare Conference
January 31, 2018
Synlogic Announces Underwriters’ Option Exercise in Full
January 24, 2018
Synlogic Announces Pricing of Public Offering of Common Stock
January 23, 2018
Synlogic Announces Proposed Public Offering of Common Stock
January 5, 2018
Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 Catalysts
Displaying 181 - 192 of 223